Home Dermatology PDF: Update on Drugs & Devices: July-August 2025

“PDF: Hydrogen Peroxide Topical Solution, 40% for the Treatment of Seborrheic Keratoses” has been added to your cart. View cart

image with pills and medical devices on yellow background

Article

PDF: Update on Drugs & Devices: July-August 2025

$1.99

PDF Download: Update on Dupilumab SC injection (Dupixent®), Garadacimab-gxii for SC injection (Andembry®), Roflumilast foam, 0.3% (Zoryve®), Ustekinumab-hmny for SC injection (Starjemza®), Ustekinumab biosimilar SC/IV use (Otulfi®) and Prademagene zamikeracel genemodified cellular sheets (Zevaskyn™).
Read online:
Update on Drugs & Devices: July-August 2025

Category: Dermatology

PDF: Update on Drugs & Devices: July-August 2025

Related products

PDF: Non-Invasive Gene Expression Testing to Rule Out Melanoma

PDF: Real-World Efficacy of Azelaic Acid 15% Gel for the Reduction of Inflammatory Lesions of Rosacea

PDF: Hydrogen Peroxide Topical Solution, 40% for the Treatment of Seborrheic Keratoses

PDF: Update on Drugs & Devices: September – October 2019